INS and type 2 diabetes mellitus: Although the autoantibody cluster of the patients with LADA and T1DM are different, the presence of these indicators reflects steady progression toward β-cell death and subsequent requirement for initiation of insulin treatment in a shorter period compared to autoantibody-negative T2DM patients.